Generate Biomedicines
Latest round
- Series C
Last raised
- Sep 2023
Total raised
- $677M
Investors
- 15
About Generate Biomedicines
, operates as a therapeutics company that offers solutions for drug discovery and development. In May 2026, Generate Biomedicines, Inc. The company offers a biomedicine platform that can produce new medications on demand across a wide range of biologic modalities, including short peptides, complicated antibodies, enzymes, cytokines, and protein compositions that have yet to be identified. The company uses machine learning technology for the identification and validation of targets and treatments, as well as the specificity of target engagement by produced proteins and the cost of identifying and producing clinical candidates. Generate Biomedicines earns revenue through strategic partnerships with pharma companies, licensing its AI-driven Generative Biology™ platform, and advancing proprietary therapeutics into clinical trials.
Who invested in Generate Biomedicines
15 investors across 3 rounds
See all investors in Generate Biomedicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Generate Biomedicines
Who invested in Generate Biomedicines?
Generate Biomedicines has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Generate Biomedicines raised?
Generate Biomedicines has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Generate Biomedicines last raise money?
Generate Biomedicines's most recent round on record is a Series C, in Sep 2023.
What does Generate Biomedicines do?
, operates as a therapeutics company that offers solutions for drug discovery and development.
Where is Generate Biomedicines headquartered?
Generate Biomedicines is headquartered in Somerville, US.
Which VCs invest in companies like Generate Biomedicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Generate Biomedicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Generate Biomedicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.